Health claims, testimonials, and FTC rules for psychedelic services

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

For licensed psilocybin service centers, facilitators, and psychedelic businesses who want to understand what the Federal Trade Commission requires when making health-related claims or using client testimonials in marketing — and how FTC rules interact with OPS’s own marketing prohibitions.

The short answer

The Federal Trade Commission Act prohibits unfair or deceptive acts or practices in commerce, and the FTC’s advertising rules apply to psychedelic businesses to the same extent they apply to any business marketing goods or services. Two areas of FTC law are most directly relevant to psilocybin service center marketing: the substantiation requirement for health and efficacy claims, and the endorsement and testimonial rules. A service center that makes unsubstantiated claims about what psilocybin services will do for clients — even claims that are technically accurate based on research — may run afoul of FTC standards if the claim implies a level of certainty or predictability that the evidence does not support. A service center that uses client testimonials without proper disclosures, or that allows social media influencers to promote its services without disclosing the material connection, has violated the FTC’s endorsement rules. The OPS prohibition on health claims and the FTC substantiation requirement overlap significantly — a claim that violates OPS rules will almost certainly also violate FTC standards, but the reverse is not always true.

The FTC’s substantiation requirement

The FTC requires that objective advertising claims — including claims about the benefits of a product or service — be substantiated by competent and reliable evidence before the claim is made. The level of substantiation required depends on the type of claim and what a reasonable consumer would understand the claim to imply.

For health and efficacy claims specifically, the FTC typically requires substantiation by competent and reliable scientific evidence — generally meaning well-designed human clinical trials. For a psilocybin service center, this standard creates a practical constraint: the clinical trial evidence for psilocybin exists and is substantial for certain conditions, but that evidence was generated in controlled research settings with specific populations, specific preparation and support protocols, and defined dose conditions. Translating research findings into marketing claims about what a service center’s psilocybin sessions will do for clients involves a gap between controlled trial conditions and real-world facilitation that the FTC’s substantiation standard requires the advertiser to account for.

A service center that says “our sessions may support emotional wellbeing and personal growth” is making a modest claim that is broadly consistent with the research and unlikely to require clinical trial-level substantiation. A service center that says “our sessions reduce depression by an average of 50%” is making a specific efficacy claim that requires competent scientific evidence at the clinical trial level — and evidence from another organization’s controlled trial does not substantiate a specific claim about what this service center’s sessions will produce. The specificity of the claim determines the level of substantiation required.

Health claims and OPS rules together

OPS rules and FTC rules operate together for psychedelic marketing, and both must be satisfied. OAR 333-333-6040 prohibits service centers from making claims that psilocybin services treat, cure, or manage health conditions. The FTC’s substantiation requirement prohibits making health or efficacy claims that are not supported by competent and reliable evidence.

A claim that is prohibited under OPS rules — “our sessions treat depression” — is also an unsubstantiated health claim under the FTC standard. But the FTC’s reach is broader: a claim could be technically permissible under OPS’s literal prohibition while still violating the FTC’s deception standard if it implies therapeutic benefit in a way that is misleading to a reasonable consumer. For example, a marketing page that is laden with research statistics about psilocybin for depression, presented alongside the service center’s session packages, may imply a treatment benefit that is deceptive under FTC standards even if it never uses the prohibited words.

Testimonials: the FTC endorsement rules

The FTC’s Endorsement Guides (16 C.F.R. Part 255, updated in 2023) govern how testimonials and endorsements may be used in advertising. The updated rules are more specific than earlier versions and address social media endorsements directly.

Three principles from the endorsement rules are most relevant to psychedelic service center marketing.

Testimonials must reflect honest opinions. A service center cannot use a fabricated testimonial, cannot instruct a client to say something they do not genuinely believe, and cannot present a testimonial as spontaneous when it was solicited or compensated. A client who received a discounted session in exchange for a positive review has received a benefit that the testimonial must disclose.

Testimonials cannot be used to imply typical results when the testimonial reflects exceptional results. The classic FTC example: using a testimonial that says “I lost 30 pounds” without disclosing that this result is atypical misrepresents what a typical client can expect. Applied to psilocybin services: using a testimonial that describes a profound, life-changing session without any context about the range of client experiences may imply that this type of outcome is typical when it is not. The FTC requires that testimonials either reflect typical results or include a clear and conspicuous disclosure of what typical results actually look like.

The FTC’s updated 2023 rules specifically address the typical results issue: if a testimonial describes results that are not representative of what a typical client experiences, the advertiser must either have reliable evidence that the described results are typical, or clearly and conspicuously disclose what typical results look like. For psilocybin services — where outcomes vary significantly between individuals — a service center relying on testimonials describing transformative experiences should consider what disclosure adequately characterizes the range of client experiences.

Material connection disclosures

The FTC requires that any material connection between an endorser and the business being endorsed be clearly and conspicuously disclosed in the endorsement itself. A material connection includes: payment or compensation; free or discounted services; a business relationship; or any other benefit that might affect the credibility of the endorsement.

A client who received a session at no charge in exchange for a testimonial must disclose that relationship. A social media influencer who promotes a service center — whether for payment, free sessions, affiliate commissions, or any other benefit — must disclose the material connection clearly in each post or piece of content.

The disclosure must be clear and conspicuous — meaning it must actually be seen and understood by reasonable consumers, not buried in fine print or below a “see more” fold. Putting “#ad” in a list of hashtags is not sufficient under the current FTC guidance if a reasonable consumer would not notice it.

Affiliate marketing and referral fees

Some service centers use affiliate marketing programs in which websites, content creators, or other parties earn a commission for client referrals. These arrangements are legal but trigger both FTC disclosure requirements and the anti-kickback considerations discussed in article 105. An affiliate who refers clients to a service center in exchange for a referral fee must disclose that material connection in any marketing content. The service center is responsible for ensuring its affiliates comply with FTC disclosure requirements — a brand cannot avoid FTC liability by delegating the non-compliant marketing to a third party.

Service centers sometimes use aggregate data — “over 500 sessions served” or “clients from 12 states” — as social proof. These claims are permissible if accurate and do not imply treatment outcomes. Claims about client satisfaction ratings — “95% of our clients would recommend us to a friend” — are permissible if the underlying data is real, the methodology is sound, and the claim is accurate as stated. They become problematic if the data is cherry-picked, the sample size is small enough that the percentage is misleading, or the claim implies efficacy rather than satisfaction.

Before and after content

Before-and-after content — descriptions or images comparing a client’s state before and after accessing psilocybin services — is a common testimonial format in wellness marketing that is particularly risky in the psychedelic context. Before-and-after comparisons imply that the service caused the change, that the change is lasting, and that comparable results are available to others. For psilocybin services, all three implications are difficult to substantiate with the required competent and reliable evidence for the specific service center’s client population. The FTC has targeted misleading before-and-after advertising in health and wellness contexts, and a service center using this format should have it reviewed for FTC compliance before publishing.

Practical compliance framework

A service center developing testimonial-based marketing should: obtain testimonials voluntarily from actual clients; document that the testimonial reflects the client’s honest opinion; confirm whether any benefit (discounted session, gift, referral fee) was provided to the client and disclose it clearly if so; review the testimonial for implied health claims that could violate OPS rules or FTC substantiation requirements; and include a clear disclosure of what typical results look like if the testimonial describes exceptional results.

A written testimonial release that addresses these points — confirming the client’s honest opinion, authorizing use of the testimonial, and documenting any compensation — is the appropriate documentation.

When public information may be enough

The FTC Act (15 U.S.C. § 45) and the FTC’s Endorsement Guides (16 C.F.R. Part 255) are publicly available. The FTC publishes detailed guidance on endorsements and testimonials, including social media disclosures, at ftc.gov. OAR 333-333-6040 is available through the Oregon Secretary of State’s administrative rules database.

When you should speak with a lawyer

A service center developing a testimonial program, an affiliate marketing arrangement, or any marketing materials that make health-adjacent claims should have those materials reviewed by an attorney familiar with both FTC advertising law and OPS marketing rules before publishing. A service center that has received an FTC civil investigative demand or inquiry should retain counsel immediately. A service center that has relied on testimonials from clients who received benefits in exchange should assess its current disclosure practices with legal counsel.

You might also want to read

This article is for general informational purposes only and does not constitute legal advice. FTC rules and OPS marketing requirements change frequently. For advice specific to your marketing materials and testimonial practices, consult a licensed attorney with experience in advertising law and psychedelic business regulation.